Stem Cell Genius
Stem Cell Genius
Podcast Description
Answering the most pressing questions about regenerative medicine from stem cells, exosomes, and PRP to the latest breakthroughs in treatment and science. R3 Stem Cell CEO David Greene, MD, PhD, MBA is one of the world's experts in regenerative medicine and answers your FAQ's with host, Samantha Brechner, MBA.
Podcast Insights
Content Themes
The podcast covers essential topics in regenerative medicine, focusing on stem cells, exosomes, and PRP, with episodes like 'Are Stem Cells and Exosomes Legal in the U.S.?' and 'What Are Stem Cells and Exosomes?' that address common misconceptions and current scientific insights.
Answering the most pressing questions about regenerative medicine from stem cells, exosomes, and PRP to the latest breakthroughs in treatment and science.
R3 Stem Cell CEO David Greene, MD, PhD, MBA is one of the world’s experts in regenerative medicine and answers your FAQ’s with host, Samantha Brechner, MBA.
Episode 7 of Stem Cell Genius answers the question of whether stem cells can cause cancer/tumors. Host Samantha Brechner speaks with David Greene, MD, PhD, MBA, founder and CEO of R3 Stem Cell.
Dr. Greene explains the different types of stem cells and whether or not they have been shown to cause cancer/tumors. You'll find this one VERY interesting!
R3 Stem Cell is the world's largest provider of regenerative therapies with 80 Centers in 8 countries. Over 28,000 stem cell procedures in 10 years with an 85% patient satisfaction rate.
Call +1(844) GET-STEM to see if you or a loved one is a candidate.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.